AAP
OCGN icon

Arax Advisory Partners’s Ocugen OCGN Stock Holding History

Arax Advisory Partners’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259 Buy
169
+67
+66% +$102 ﹤0.01% 5070
2026
Q1 		$185 Hold
102
– – ﹤0.01% 3553
2025
Q4 		$138 Sell
102
-67
-40% -$95 ﹤0.01% 3779
2025
Q3 		$275 Buy
+169
New +$187 ﹤0.01% 3426

Other funds holding OCGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Arax Advisory Partners's OCGN Position: Q2 2026 in Review

Arax Advisory Partners increased its Ocugen (OCGN) stake by 66% in Q2 2026, buying an estimated $102 and bringing the position to 169 shares worth $259. The position accounts for ﹤0.01% of the portfolio, ranked #5070.

Arax Advisory Partners first reported a position in OCGN in Q3 2025 and has held it in 4 quarters since. The position peaked at $275 in Q3 2025. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Arax Advisory Partners held 169 shares of Ocugen worth $259 as of Q2 2026.
  • Arax Advisory Partners bought 67 Ocugen shares in Q2 2026, an estimated $102.
  • Ocugen made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #5070 holding.
  • Arax Advisory Partners first reported a position in Ocugen in Q3 2025 and has held it in 4 quarters since.
  • Arax Advisory Partners's Ocugen position peaked at $275 in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.